Choosing a fertility clinic is one of the most consequential decisions an infertile couple makes — and one of the least well-guided. Most couples approach the decision with the tools available to any consumer: online reviews, word-of-mouth recommendations, clinic websites, and the headline success rates that clinics prominently advertise.
None of these are reliable guides to clinical quality. Online reviews reflect patient experience, which may or may not correlate with clinical outcomes. Word of mouth captures one person's experience with one case that may be very different from yours. Clinic websites are marketing documents, not clinical assessments. And headline success rates, as explained in our dedicated article on why clinics quote high success rates, are frequently constructed in ways that make them incomparable between clinics and clinically meaningless for individual prognosis.
What couples actually need to evaluate a fertility clinic is a framework — a set of specific, clinically meaningful questions that probe the dimensions of clinical quality that actually matter: the depth of investigation, the quality of the laboratory, the expertise and focus of the treating specialist, the honesty of communication, and the transparency of reported outcomes.
This article provides that framework — eight questions that every couple should ask before committing to fertility treatment at any clinic, with an explanation of what each question is designed to reveal and how to evaluate the answer.
Question 1: Is the Lead Doctor a Dedicated Fertility Specialist, or a Gynecologist Who Also Performs IVF?
This is the most fundamental question — and the one most frequently overlooked, because the distinction is not always visible in how doctors present themselves.
A dedicated fertility specialist — a doctor whose entire clinical practice is reproductive medicine — brings a depth of subspecialty experience to complex fertility cases that a generalist gynecologist who performs IVF alongside deliveries, gynecological surgeries, and general women's health cannot replicate. As explained in detail in our article on what a fertility super specialist is and why it matters, the pattern recognition, the diagnostic instinct, and the procedural competence that come from concentrating an entire career on one specific clinical domain are qualitatively different from the expertise developed in a divided practice.
What to ask: What proportion of the doctor's clinical work is specifically fertility and IVF? Do they perform obstetric deliveries and general gynecological surgeries alongside fertility treatment? What is their specific subspecialty qualification in reproductive medicine?
What the answer reveals: A doctor who spends half their clinical time on obstetrics and general gynecology and the other half on IVF is not the same as a doctor whose entire practice is fertility medicine. The former is a competent generalist with IVF capability. The latter is a subspecialist whose accumulated experience in the specific challenges of complex fertility cases is substantially greater.
What Metro IVF offers: Dr. Ashish Soni is North India's first fertility super specialist — a doctor whose entire career and entire clinical practice is dedicated to reproductive medicine. He does not perform obstetric deliveries. He does not manage general gynecological conditions. His clinical attention is concentrated entirely on the challenge of helping couples conceive — and the depth of clinical judgment that this exclusive focus produces is visible in the outcomes he achieves in the most difficult cases.
Question 2: Does the Clinic Routinely Test Sperm DNA Fragmentation as Part of Every Male Evaluation?
This question probes the thoroughness of the male infertility investigation — and, by extension, the clinical standard of the entire investigation protocol.
As established throughout this content library, sperm DNA fragmentation is one of the most commonly missed causes of IVF failure. A man with a completely normal semen analysis can have severely elevated DNA fragmentation — invisible to standard assessment — that is compromising embryo development in ways that cannot be seen or addressed unless the test is specifically performed.
A clinic that tests sperm DNA fragmentation routinely — for every male partner, regardless of semen analysis results — is operating at a level of male fertility assessment that goes beyond the standard. A clinic that tests it only when the semen analysis is abnormal is missing the majority of cases where elevated DFI is clinically relevant, because those cases are precisely the ones where the standard analysis appears normal.
What to ask: Is sperm DNA fragmentation testing included as a routine component of every male evaluation, or is it ordered only in specific circumstances?
What the answer reveals: The completeness of the male fertility assessment. If the answer is "only when semen analysis is abnormal" — the investigation is incomplete for a significant proportion of couples. If the answer is "for every male partner" — the investigation is thorough.
Question 3: Does the Clinic Perform Hysteroscopy as a Standard Pre-IVF Assessment, or Only When Ultrasound Suggests an Abnormality?
This question probes the completeness of the uterine assessment — one of the most consistently underperformed components of the standard fertility investigation.
Transvaginal ultrasound is an excellent screening tool for many uterine conditions — large fibroids, obvious anomalies, significant endometrial pathology. But standard ultrasound misses a significant proportion of the uterine cavity abnormalities most relevant to implantation — small polyps, mild intrauterine adhesions, small submucosal fibroids, and chronic endometritis — that are associated with reduced implantation rates and that can be found only by direct visualization of the cavity through hysteroscopy.
A clinic that performs hysteroscopy as a standard component of the pre-IVF assessment — before the first cycle, not only after cycles have failed — is identifying and addressing these cavity abnormalities before they have their chance to impair implantation. A clinic that performs hysteroscopy only when ultrasound suggests an abnormality is relying on a screening tool that will miss a meaningful proportion of relevant findings.
What to ask: Is hysteroscopy part of the standard pre-IVF work-up at this clinic, or is it reserved for cases where ultrasound finds something concerning?
What the answer reveals: Whether the clinic is performing a thorough uterine assessment or a standard one. The thorough assessment finds more — and finding more translates into more corrected conditions, more appropriate transfer timing, and better outcomes.
Question 4: Does the Clinic Discuss ERA Testing for Patients with Repeated Implantation Failure?
ERA — endometrial receptivity analysis — is the test that identifies a displaced implantation window, the condition in which the endometrium's receptive phase occurs at a different time from the standard assumed timing, causing every transfer timed to the standard protocol to arrive when the endometrium is not yet — or is no longer — receptive.
Displaced implantation window is present in approximately 20 to 30 percent of women with recurrent implantation failure. It is entirely undetectable by standard assessment — ultrasound and blood tests cannot identify it. ERA testing requires a specific endometrial biopsy analyzed by gene expression profiling, with a result that tells the clinician whether the endometrium is receptive at standard timing or is pre- or post-receptive by a specific number of hours.
Awareness of ERA — and the clinical judgment to know which patients warrant it — is a marker of subspecialty-level endometrial assessment. A clinic whose treating doctor has not discussed ERA with a patient who has had three failed transfers of good-quality embryos has not exhausted the investigation of why those transfers failed.
What to ask: For patients with repeated implantation failure, is ERA testing discussed and offered?
What the answer reveals: Whether the clinic is investigating the endometrial component of recurrent failure at a subspecialty level or at a standard level.
Question 5: How Does the Clinic Report Success Rates — Per Initiated Cycle or Per Transfer, and as Live Birth Rate or Pregnancy Test Rate?
As explained in comprehensive detail in our article on why clinics quote high success rates, the definition of "success" and the denominator used to calculate the rate can transform the same underlying data into numbers that differ by twenty to thirty percentage points.
The only success rate definition that answers the question every couple is asking — if I start an IVF cycle, what is the probability that I will have a baby — is live birth rate per initiated cycle. Any other definition answers a different, less clinically meaningful question.
What to ask: Is your quoted success rate a live birth rate or a pregnancy test / clinical pregnancy rate? Is it calculated per initiated cycle, per retrieval, or per transfer? What is the age breakdown of the patients in this rate?
What the answer reveals: Whether the clinic is providing clinically meaningful success rate information or a marketing figure. A clinic that gives a straightforward, specific answer to these questions — even if the resulting number is lower than a competitor's inflated figure — is demonstrating the transparency that genuine clinical quality requires. A clinic that becomes evasive or cannot clearly explain how its rate is calculated is demonstrating the opposite.
Question 6: Does the Clinic Have In-House Surgical Sperm Retrieval Capability — TESA and PESA?
This question is particularly relevant for couples where male factor infertility is present or suspected — but it also serves as a proxy for the overall surgical and clinical capability of the center.
Surgical sperm retrieval — TESA (testicular sperm aspiration) for men with azoospermia — requires that the fertility specialist has specific surgical training and that an experienced embryologist is immediately available to assess and process the retrieved sperm on the same day as the female partner's egg retrieval.
A clinic that offers this capability in-house — with the fertility specialist performing the retrieval and the laboratory integrated to allow simultaneous retrieval and egg collection coordination — offers a level of male infertility management that is substantially more comprehensive than a clinic that refers male surgical cases externally. The quality of in-house coordination between the surgical team and the embryology laboratory directly affects the outcome of sperm retrieval procedures.
What to ask: Does the clinic offer TESA and PESA in-house, performed by the fertility specialist rather than referred to an external urologist? Is the embryology laboratory integrated with the retrieval procedure to allow same-day processing?
What the answer reveals: The completeness of the clinic's male infertility capability and the degree of integration between its clinical and laboratory functions.
Question 7: What Is the Embryology Laboratory's Approach to Quality Assurance?
The embryology laboratory — the room where fertilization, embryo culture, and cryopreservation occur — is the clinical environment that most directly determines the quality of the embryos produced in an IVF cycle. The quality of the laboratory equipment, the culture media, the incubators, the cryopreservation technique, and the experience and training of the embryologists who work in it are among the most important determinants of IVF outcomes.
And yet laboratory quality is the dimension of clinic evaluation that couples most consistently fail to assess — because it is invisible, because couples do not know what questions to ask about it, and because clinics do not typically lead with information about their laboratory when marketing to patients.
What to ask: What type of incubators does the laboratory use — conventional or time-lapse? What culture media does the laboratory use for embryo development? What is the laboratory's embryo vitrification survival rate? How long have the embryologists been working in IVF specifically? Is the laboratory certified or accredited by any external body?
What the answer reveals: A clinic whose clinical team can answer these questions specifically and transparently is a clinic whose laboratory function is taken seriously and communicated honestly. A clinic that deflects from laboratory questions toward outcome statistics or testimonials may be managing the perception that something about the laboratory deserves deflection.
The specific answers matter less than the transparency and specificity with which they are given. A clinic that tells you their vitrification survival rate is 92 percent, that they use a specific recognized culture medium, that their embryologists have ten years of IVF-specific experience, and that they use time-lapse monitoring for all embryos is a clinic whose laboratory culture supports honest quality assessment. A clinic that responds to these questions with general reassurance is not providing the information you need.
Question 8: How Does the Clinic Communicate Results and Support Patients Through Difficult Moments?
The clinical quality of an IVF cycle is not measured only in the biological outcomes it produces. It is also measured in the quality of the clinical relationship — the communication, the support, the honesty, and the accessibility that the clinic provides throughout the process.
A specific dimension of this that every couple should probe is how the clinic communicates difficult results — a failed cycle, a miscarriage, a finding that changes the prognosis. These moments are the ones in which the quality of the clinical relationship is most starkly revealed. A clinic that communicates difficult results specifically, honestly, and with the clinical depth that allows the couple to understand what happened and what it means for next steps — rather than with vague reassurance and a default recommendation to try again — is a clinic operating at a different level of clinical engagement.
What to ask: When an IVF cycle fails, what specific feedback does the clinic provide about why it failed and what should change? Does the fertility specialist personally discuss results with patients, or is this delegated? Is there a counseling resource for couples dealing with failed cycles or pregnancy loss?
What the answer reveals: Whether the clinical team understands that the relationship with the patient does not end with a negative result — and that the most important clinical conversation of the cycle is often the one that follows the failure, not the one that precedes the next attempt.
Applying the Framework
These eight questions do not produce a single numerical score for clinic quality. They produce a picture — of the depth of investigation, the thoroughness of assessment, the transparency of communication, and the commitment to genuine clinical engagement rather than efficient patient processing.
A clinic that answers all eight questions clearly, specifically, and honestly — even when some of those honest answers are less flattering than a competitor's inflated equivalents — is demonstrating the clinical culture that these questions are designed to identify.
Metro IVF in Ambikapur — led by Dr. Ashish Soni, North India's first fertility super specialist — answers every one of these questions with specificity and transparency. Sperm DNA fragmentation is tested for every male partner. Hysteroscopy is performed as a standard pre-IVF assessment. ERA is discussed with every patient with repeated implantation failure. Success rates are reported honestly with the definitions clearly specified. TESA and PESA are performed in-house by Dr. Soni. The laboratory team's qualifications are openly discussed. And the communication after difficult results is specific, honest, and based on the actual clinical findings of the cycle.
That is the answer to every one of the eight questions — and it is the answer that the questions are designed to find.
Your Next Step
If you are evaluating fertility clinics — whether for the first time or after experience elsewhere that has left you with questions — apply this framework to the clinics you are considering. Ask the eight questions. Listen to the specificity and honesty of the answers.
And if you want to experience what the clinic that answers all eight questions clearly looks like — book your consultation with Dr. Ashish Soni at Metro IVF in Ambikapur.
Metro IVF Test Tube Baby Center Ambikapur, Chhattisgarh metrofertility.in Led by Dr. Ashish Soni — North India's First Fertility Super Specialist
Eight questions. One right answer. Book your consultation with Dr. Ashish Soni at Metro IVF today.